Holly Dolejsi is member of Robins Kaplan LLP. She is a practice areas Defective & Dangerous Products and Class Action.
Representing individuals and families who have been injured by medical devices and pharmaceuticals.
Currently serving as Co-Lead Counsel in the Farxiga multidistrict litigation in the Southern District of New York.
Currently litigating cases involving gastrointestinal injuries linked to the prescription hypertension drug Benicar, as well as cases involving people implanted with the Stryker Rejuvenate and ABG II Hip implants.
Experienced at representing personal injury and Federal Employers’ Liability Act clients.